Carol O’Hear

Carol O’Hear

Company: Gilead Sciences

Job title: Vice President, Clinical Development, Hematology Franchise Head


Industry Leader’s Fireside Chat: A Roundup of Clinical Development with a Focus on Clinical Validation 9:30 am

• Unraveling clinical success stories to reaffirm the potential of macrophage-directed therapies and boost investment in the macrophage space • Addressing key dosing, safety, and efficacy challenges to accelerate clinical resultsRead more

day: Day Two

Rational Combinations with Magrolimab in Hematologic Malignancies 8:30 am

• Demonstrating robust preclinical programs to create a rational therapeutic design and combination strategy • Clinical efficacy of magrolimab in hematologic malignancies • Share safety considerations of targeting CD47 and the toxicity profile seen in the clinicRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.